Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

March 27, 2013

How the Digital Revolution Will Create Better Health Care

Last night, cardiologist Dr. Eric Topol, chief academic officer of Scripps Health, was a guest on The Colbert Report, where he discussed his new book, “The…

Posted by James A. Datin

January 29, 2013

6 Trends That Will Shape Healthcare in 2013

With President Obama winning another four years in the oval office, the palpable uncertainty created by the Supreme Court ruling on the Affordable Care Act…

Posted by James A. Datin

October 12, 2012

Anatomy of a Deal: Avid Radiopharmaceuticals

This morning, I presented at the 2012 Annual RBC Biotech Conference, which focused on the “Biotech Success Stories of the [Philadelphia] Region”. I was asked…

Posted by James A. Datin

September 20, 2012

Life Sciences Entrepreneurship: How to Keep Pennsylvania Competitive

A recent article in Harvard Business Review pointed to the human genome as the next focus for diagnosing and treating diseases. The authors call for…

Posted by James A. Datin

May 31, 2012

Putting Growth Capital to Work in Philadelphia

On average, Safeguard Scientifics evaluates more than a thousand business plans each year—that’s 20 business plans per week. Last year, we chose to partner with…

Posted by James A. Datin

January 12, 2012

J.P. Morgan Healthcare Conference Recap: How Technology Can Improve Healthcare

We’ve talked about Enterprise 3.0 before—how the evolution of social media, big data, mobile technology, Internet of Things, and cloud computing are transforming the enterprise.…

Posted by James A. Datin

January 10, 2012

Life Sciences Trends for 2012: Healthcare IT, Diagnostics, and Personalized Medicine

This week, Safeguard Scientifics’ life sciences team is in San Francisco attending J.P. Morgan’s 30th Annual Healthcare Conference, one of the healthcare industry’s largest annual meetings.…

Posted by James A. Datin

January 9, 2012

Alverix Technology Key to Landmark Flu Test from BD

In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…

Posted by James A. Datin

January 3, 2012

8 Reasons Why We’re Excited about 2012

Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious.…

Posted by James A. Datin

Content